Data updated: Mar 10, 2026
PROPANTHELINE BROMIDE
PROPANTHELINE BROMIDE
Approved 1974-09-09
4
Indications
--
Phase 3 Trials
51
Years on Market
Details
- Status
- Discontinued
- First Approved
- 1974-09-09
- Routes
- ORAL
- Dosage Forms
- TABLET
PROPANTHELINE BROMIDE Approval History
Loading approval history...
What PROPANTHELINE BROMIDE Treats
4 FDA approvalsOriginally approved for its first indication in 1974 . Covers 4 distinct patient populations.
- Other (4)
Other
(4 approvals)- • Approved indication (Sep 1974)
- • Approved indication (Jan 1975)
- • Approved indication (Aug 1976)
- • Approved indication (Oct 1993)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
PROPANTHELINE BROMIDE FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.